How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | DROPFuse Science Inc | KASH.CNKASH.CN | PARABanzai International, Inc. | MWAIMedWellAI, Inc. |
|---|---|---|---|---|
| Type | — | Company | Company | Company |
| Price | $0.0043▼ 0.00 (4.44%) | C$0.03▲ 0.00 (0.00%) | $0.4702▼ 0.04 (7.80%) | $0.298▲ 0.02 (6.50%) |
| Health scoreComposite of profitability, growth, debt and accounting quality. | not reported | 2.0/10 | 4.7/10 | 2.0/10 |
| Market value | $1.1M | $2.2M | $5.0M | $1.9M |
| Revenue | — | $1.3K | $12.2M | $527.9K |
| Profit | — | -$763.9K | -$22.5M | -$1.6M |
| Revenue growthChange in sales versus the prior year. | — | -79.8% | 168.6% | -11.2% |
| Gross marginShare of sales left after the direct cost of producing them. | — | -28473.2% | 82.0% | — |
| Operating marginShare of sales left after running the business, before interest and tax. | — | -53659.0% | -151.8% | -234.2% |
| Profit marginProfit kept from each dollar of sales. | — | -58906.6% | -184.9% | -301.1% |
| Free cash flow marginCash left after capital spending, as a share of sales. | — | -26679.7% | — | -58.2% |
| Return on equityProfit against the owners' stake in the company. | — | -148.9% | -279.2% | 19.9% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | -108.0% | -187.1% | — |
| P/E ratioPrice paid per dollar of annual profit. | — | — | — | — |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | — | — |
| Price to book | — | 4.24x | 0.62x | -0.24x |
| Debt to equityTotal liabilities compared with owners' stake. | — | 1.03x | 2.93x | -1.00x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | not reported | 3/8 | 4/8 | 3/7 |
| Bankruptcy riskAltman Z-Score zone. | not reported | distress | distress | n/a for banks |